News & Events

Vanderbilt Study Spots Economic Link With Drug-Dependent Newborns

Places with high rates of joblessness also seem to have outsized problems with drug-dependent newborns. That's the central finding in a new Vanderbilt study published in the Journal of the American Medical Association on Tuesday. Researchers looked at 6.2 million births across eight states, including Tennessee. And for those exposed to opioids in the womb, the map matches up very closely to long-term unemployment rates.

Melania Trump meets with families with babies dependent on drugs during Vanderbilt hospital visit

Melania Trump arrived in Nashville on Tuesday to visit Monroe Carell Jr. Children’s Hospital at Vanderbilt to be briefed on babies born dependent on drugs.  Trump blew bubbles with pediatric patients and got down on kid-level to play trains after attending a roundtable on treatment options for infants of opioid-addicted mothers born in conditions of withdrawal.

Early discharge of NAS infants prolongs treatment

Infants who are diagnosed with drug withdrawal after birth who are treated with medication as outpatients at home are treated three times longer than infants treated solely as inpatients, according to a new Vanderbilt study. Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that occurs shortly after birth, and can occur when an infant is exposed to an opioid during the pregnancy.

Integrated, multidisciplinary approach key to opioid fight: panel

No single approach will end the epidemic of fatal overdoses caused by addiction to opioid painkillers and heroin that is ravaging this country, the U.S. Assistant Secretary for Health, Adm. Brett Giroir, MD, warned Tuesday during a panel discussion in a packed lecture hall at Vanderbilt University Medical Center.

Team Hope program’s mission is to enhance care for newborns with NAS

A collaborative program across units at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospital at Vanderbilt is changing the way nurses and doctors care for newborns diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS).